Ariel Williams1, Natasha Greene1, K Kimbro2. 1. Julius l. Chambers Biomedical/ Biotechnology Research Institute, North Carolina Central University, 1801 Fayetteville St., Durham, NC 27707, USA. 2. Julius l. Chambers Biomedical/ Biotechnology Research Institute, North Carolina Central University, 1801 Fayetteville St., Durham, NC 27707, USA; Department of Biomedical and Biologically Sciences, North Carolina Central University, 1801 Fayetteville St., Durham, NC 27707, USA. Electronic address: kkimbro@nccu.edu.
Abstract
PURPOSE: Obesity has emerged as one of the biggest health crisis and is the leading cause of death and disabilities around the world. BMI trends suggest that majority of the increase in T2D is resulting from the increased prevalence of obesity. In fact, 85.2% of people with T2D are overweight or obese. The highest prevalence for obesity is seen in non-Hispanic, African American women (56.6%). T2D is classified as an inflammatory disease because of elevated, circulating pro-inflammatory cytokines and acute-phase inflammatory proteins. This study was designed to determine how high HbA1c and serum glucose correlate with circulatory cytokine levels in obese, African American women. METHODS: We investigated cytokine/chemokine serum levels using a multiplex assay. Then we used Pairwise Pearson Correlation Test to determine the relationship between clinical metabolic parameters and cytokine/chemokine serum levels. RESULTS: The results indicated that participants with elevated HbA1c exhibited an up regulation of IL-3, IL-4, IL-7, TNF-α, IFN-α2 and CX3CL1 serum levels compared to participants with normal HbA1c. These cytokines were also correlated with several clinical metabolic parameters. CONCLUSIONS: The results suggest that IL-3, IL-4, IL-7, TNF-α, IFN-α2 and CX3CL1 serum levels may contribute to the development and onset of type 2 diabetes.
PURPOSE:Obesity has emerged as one of the biggest health crisis and is the leading cause of death and disabilities around the world. BMI trends suggest that majority of the increase in T2D is resulting from the increased prevalence of obesity. In fact, 85.2% of people with T2D are overweight or obese. The highest prevalence for obesity is seen in non-Hispanic, African American women (56.6%). T2D is classified as an inflammatory disease because of elevated, circulating pro-inflammatory cytokines and acute-phase inflammatory proteins. This study was designed to determine how high HbA1c and serum glucose correlate with circulatory cytokine levels in obese, African American women. METHODS: We investigated cytokine/chemokine serum levels using a multiplex assay. Then we used Pairwise Pearson Correlation Test to determine the relationship between clinical metabolic parameters and cytokine/chemokine serum levels. RESULTS: The results indicated that participants with elevated HbA1c exhibited an up regulation of IL-3, IL-4, IL-7, TNF-α, IFN-α2 and CX3CL1 serum levels compared to participants with normal HbA1c. These cytokines were also correlated with several clinical metabolic parameters. CONCLUSIONS: The results suggest that IL-3, IL-4, IL-7, TNF-α, IFN-α2 and CX3CL1 serum levels may contribute to the development and onset of type 2 diabetes.
Authors: Marc Y Donath; Desiree M Schumann; Mirjam Faulenbach; Helga Ellingsgaard; Aurel Perren; Jan A Ehses Journal: Diabetes Care Date: 2008-02 Impact factor: 19.112
Authors: Barbara Menart-Houtermans; Ruth Rütter; Bettina Nowotny; Joachim Rosenbauer; Chrysi Koliaki; Sabine Kahl; Marie-Christine Simon; Julia Szendroedi; Nanette C Schloot; Michael Roden Journal: Diabetes Care Date: 2014-08 Impact factor: 19.112
Authors: Haley E Rymut; Laurie A Rund; Courtni R Bolt; María B Villamil; Diane E Bender; Bruce R Southey; Rodney W Johnson; Sandra L Rodriguez-Zas Journal: Animals (Basel) Date: 2021-04-01 Impact factor: 2.752
Authors: Haley E Rymut; Laurie A Rund; Courtni R Bolt; Maria B Villamil; Bruce R Southey; Rodney W Johnson; Sandra L Rodriguez-Zas Journal: Animals (Basel) Date: 2021-08-01 Impact factor: 2.752
Authors: Diego T Brunelli; Vinicius O Boldrini; Ivan L P Bonfante; Renata G Duft; Keryma Mateus; Leonardo Costa; Mara P T Chacon-Mikahil; Ana M Teixeira; Alessandro S Farias; Cláudia R Cavaglieri Journal: Front Immunol Date: 2022-01-05 Impact factor: 7.561